Navigation Links
Vapotherm Announces Commercial Launch of Flowrest® Homecare Device
Date:7/26/2011

STEVENSVILLE, Md., July 26, 2011 /PRNewswire-USNewswire/ -- Vapotherm announced today the launch of Flowrest®, a High Flow Therapy device developed specifically for homecare and other low acuity environments. The initial launch will focus on the U.S. and European markets.

Vapotherm's Flowrest® is designed specifically for chronic respiratory patients in home and other extended care environments.  According to the World Health Organization, chronic respiratory diseases impact hundreds of millions of people worldwide, with asthma and COPD alone totaling almost 300 million globally.  Other chronic conditions include allergic rhinitis, pulmonary fibrosis and pulmonary hypertension.  In the U.S. alone, COPD affects more than 16 million and over 1 million patients are prescribed long-term oxygen therapy.  Flowrest® is indicated to deliver heated, humidified breathing gases via nasal cannula at flow rates from 15 to 35 liters per minute.

"In response to pre-launch demand, we are excited to begin shipping Flowrest® to our customers in the U.S. and Europe," said Nick Macmillan, Home Care Segment Manager at Vapotherm.  "The Flowrest® provides patients with a new option for respiratory assistance that overcomes the well documented issues associated with mask therapies including problems with patient compliance and comfort.  Through our patented technology, we have empowered the simple and comfortable nasal cannula to provide higher levels of respiratory support."

Robert Storey, CEO of Vapotherm, commenting on the launch stated, "We wanted to provide a solution to the constant requests we received from hospital customers for a homecare option.  Worldwide, health care systems are looking for ways to get patients out of the hospital faster and sustain them at home to minimize the risk that they will have to return to the hospital.  Flowrest® is our answer to the continuity of care in High Flow Therapy."

Vapotherm has been the leading provider of High Flow Therapy devices to hospitals for over ten years, and created the category of High Flow Nasal Cannula beginning in 2001 with its first device, the 2000i.  The Company's flagship product, the Precision Flow®, is currently used in hospitals worldwide in adult, pediatric and neonatal applications.  The Flowrest® was created to fill the need for High Flow Therapy outside of the short term acute care environment.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and homecare use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive respiratory therapy technologies, especially for the treatment of acute and chronic breathing disorders. For more information, visit www.vtherm.com.

Vapotherm, Inc.
198 Log Canoe Circle
Stevensville, MD 21666
Phone (410) 604-3977
Fax (410) 604-3978

Contact:  Kevin Thibodeau, Executive Vice President of Sales and Marketing
410-604-3977


'/>"/>
SOURCE Vapotherm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vapotherm Announces Approval in Canada for New High Flow Device Designed for Heliox
2. Vapotherm Announces New Exclusive Distribution Agreement with Hippo Medical for South Korea
3. Vapotherm® Receives FDA 510(k) Clearance for Flowrest® Homecare Device
4. Vapotherm, Inc. Announces CE Mark Approval for Flowrest® Homecare Device
5. Accuray Announces Proposed Offering of $75 Million Convertible Senior Notes
6. arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology
7. NuMe Health Announces Closing of Series A-1 Financing Round
8. Amgen Announces Webcast of 2011 Second Quarter Financial Results
9. Lanx, Inc. Announces Aspen™ Spinous Process Fixation System Clinical Data at IMAST
10. Prasco® Announces Authorized Generic Agreement with Shionogi Inc.
11. Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicines Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... LONDON , May 24, 2016 ... erfüllt beide primären Endpunkte ... und Überlegenheit in ‚ausgezeichneter plus guter ... aufsteigenden Colons    ,      (Logo: ... B.V. gab heute neue positive Daten von der ...
(Date:5/24/2016)... Mass. , May 24, 2016  NxStage Medical, ... technology company focused on advancing renal care, today announced ... plans to participate in the following schedule of investor ... be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, June ...
(Date:5/24/2016)... HONG KONG , May 24, 2016 /PRNewswire/ ... primer stent de doble terapia del mundo, introduce ... fístula arteriovenosa. OrbusNeich, una compañía global ... cambian las vidas, ha expandido su cartera incluyendo ... catéteres balón JADE™ y Scoreflex™ PTA son los ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... Each year ... complementary medicine. Allison Outerbridge is this year’s Life University winner of ... at the university’s Student Leadership Awards ceremony. , Outerbridge is approaching her last ...
(Date:5/26/2016)... ... 26, 2016 , ... W.S. Badger Co. Inc ., the maker of ... When Work Works Award for its use of effective workplace strategies to increase business ... project administered by the Families and Work Institute (FWI) and the Society for Human ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are nearly 14.5 million ... million cancer survivors worldwide. On Sunday, June 5, 2016, communities around the world will ... Survivors Day®. , National Cancer Survivors Day® is an annual worldwide Celebration of ...
(Date:5/26/2016)... ... May 26, 2016 , ... An April Gallup survey found ... The 550 employees of Sun Health Senior Living (SHSL) may not share ... their doctor and prescription copays for the year, while holding the line on increasing ...
Breaking Medicine News(10 mins):